Finoriq research workspace
Bausch Health Companies Inc. (BHC) Institutional Holdings & 13F Ownership
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical. Review BHC institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
- Company
- Bausch Health Companies Inc. (BHC)
- Ticker
- BHC
- Market Cap
- $1.8B
- Latest Price
- $4.71
- Industry
- Biotech & Pharma
Bausch Health Companies Inc. (BHC) Top Institutional Holders
Top current 13F holders indexed for Bausch Health Companies Inc. (BHC). Latest period 2026-03-31.
| Rank | Investor | Value | Portfolio | Filing |
|---|---|---|---|---|
| 1 | John PaulsonCIK 0001035674 | $395.6M | 12.7% | Filing2026-05-15 |
| 2 | Ray DalioCIK 0001350694 | $3.6M | 0.02% | Filing2026-05-15 |
| 3 | Joel GreenblattCIK 0001510387 | $326,797 | 0.0% | Filing2026-05-15 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.